Scarica l'app Stockscreener
142.68
0.55%
-0.7924
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BDX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$143.47
Aprire:
$143.95
Volume 24 ore:
2.77M
Relative Volume:
0.99
Capitalizzazione di mercato:
$39.17B
Reddito:
$21.37B
Utile/perdita netta:
$1.41B
Rapporto P/E:
36.18
EPS:
3.9437
Flusso di cassa netto:
$3.07B
1 W Prestazione:
-0.33%
1M Prestazione:
-10.01%
6M Prestazione:
-25.82%
1 anno Prestazione:
-18.66%
Intervallo 1D:
$142.01
$145.58
Intervallo di 1 settimana:
$142.01
$148.75
Portata 52W:
$142.01
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Nome
Becton Dickinson Co
Settore
Industria
Telefono
(201) 847-6800
Indirizzo
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
142.15 | 39.53B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
440.01 | 149.15B | 10.58B | 3.00B | 2.83B | 8.2437 |
ALC
Alcon Inc
|
66.03 | 31.04B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.05 | 30.60B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
204.15 | 29.28B | 5.54B | 1.52B | 1.74B | 10.37 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-10 | Ripresa | Goldman | Neutral |
| 2026-02-10 | Ripresa | Barclays | Overweight |
| 2026-02-03 | Ripresa | Citigroup | Buy |
| 2025-09-25 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-02 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-05-05 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2022-07-11 | Downgrade | Citigroup | Neutral → Sell |
| 2022-06-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Ripresa | Raymond James | Mkt Perform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Ripresa | Goldman | Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-07 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-02-07 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Iniziato | Deutsche Bank | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-06-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-01-19 | Ripresa | BofA/Merrill | Buy |
| 2018-01-05 | Aggiornamento | Citigroup | Sell → Neutral |
| 2018-01-05 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2017-12-29 | Reiterato | Deutsche Bank | Buy |
Mostra tutto
Becton Dickinson Co Borsa (BDX) Ultime notizie
Is Wall Street Bullish or Bearish on Becton, Dickinson and Company Stock? - Barchart.com
Peter Menziuso Named EVP and President, BD Interventional – Company Announcement - Financial Times
Becton Dickinson and Co stock (US0758871091): earnings beat and strategic focus keep medtech giant i - AD HOC NEWS
DNB Asset Management AS Has $22.28 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Northwestern Mutual Wealth Management Co. Increases Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson (BDX) Delivers Solid Q2 Performance, Barclays Lifts Target - Insider Monkey
Becton Dickinson's (NYSE:BDX) Strong Earnings Are Of Good Quality - Moomoo
Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight - GlobeNewswire Inc.
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
BDX Stock Price, Quote & Chart | BECTON DICKINSON AND CO (NYSE:BDX) - ChartMill
Becton, Dickinson and Company (BDX) Announces €600 Million Euro Notes Offering - GuruFocus
Becton Dickinson & Co (BDX) News Flow - Moomoo
Becton Dickinson Announces €600 Million Senior Notes Offering - TipRanks
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Becton Dickinson launches €600M euro-note offering to refinance 2026 notes - TradingView
This Becton Dickinson Insider Increased Their Holding In The Last Year - Moomoo
Becton, Dickinson and Company $BDX Shares Bought by First Eagle Investment Management LLC - MarketBeat
Crossmark Global Holdings Inc. Grows Stake in Becton, Dickinson and Company $BDX - MarketBeat
May 11, 2026FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses - Becton Dickinson
Is Becton Dickinson & Co (BDX) a Bargain After 4.2% Drop? GF Val - GuruFocus
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
BD appoints Vitor Roque as permanent CFO - MedTech Dive
Dental Needle Market Is Going to Boom |• BD (Becton Dickinson and Company) • Terumo Corporation - openPR.com
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $204 - Moomoo
Jim Cramer on Becton, Dickinson: “The Company Showed Excellent Execution Across the Board” - Insider Monkey
Becton, Dickinson and Company Q2 Earnings Call Highlights - sharewise.com
Becton, Dickinson & Co. Hits Day High with Strong 5.87% Surge - Markets Mojo
4: Statement of changes in beneficial ownership of securities - Becton Dickinson
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says - Moomoo
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $175 - 富途牛牛
Becton, Dickinson and Company (NYSE:BDX) Q2 2026 Earnings Call Transcript - Insider Monkey
Pregnancy Detection Kits Market Analysis Report 2026 - GlobeNewswire Inc.
Research Alert: CFRA Maintains Hold Rating On Shares Of Becton, Dickinson And Company - Moomoo
Becton, Dickinson and Company (NYSE:BDX) Price Target Raised to $190.00 at Evercore - MarketBeat
Becton Dickinson & Co(BDX) Stock Options Chain | Quotes & News - Moomoo
Becton Dickinson Q2 FY26 slides: EPS beat drives guidance raise By Investing.com - Investing.com South Africa
Update: Becton, Dickinson Shares Rise After Higher Fiscal Q2 Results; Vitor Roque Named as CFO - Moomoo
Becton Dickinson Lifts EPS Outlook Amid Mixed Headwinds - TipRanks
Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180 - Moomoo
Becton Dickinson hikes profit outlook, names CFO - MSN
Is the options market predicting a spike in Becton Dickinson stock? - MSN
Why Is Becton Dickinson Stock Gaining Thursday?Becton Dickinson (NYSE:BDX) - Benzinga
Deals tracker: Cross Country Healthcare to be acquired for $437M - Modern Healthcare News
Becton Dickinson Q2 FY26 slides: EPS beat drives guidance raise - Investing.com
TD Cowen Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $163 - Moomoo
Earnings call transcript: Becton Dickinson Q2 2026 beats earnings expectations By Investing.com - Investing.com Australia
Earnings call transcript: Becton Dickinson Q2 2026 beats earnings expectations - Investing.com
Q2 2026 Becton Dickinson and Co Earnings Call Transcript - GuruFocus
Research Alert: Becton Dickinson Tops Q1 Estimates, Bumps Forward Guidance - Moomoo
Becton Dickinson (BDX) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance UK
Becton Dickinson Co Azioni (BDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):